Chemoinformaics analysis of ECHIOIDININ 5-O-GLUCOSIDE
| Molecular Weight | 446.408 | nRot | 5 |
| Heavy Atom Molecular Weight | 424.232 | nRig | 24 |
| Exact Molecular Weight | 446.121 | nRing | 4 |
| Solubility: LogS | -3.682 | nHRing | 2 |
| Solubility: LogP | 1.438 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 59.4294 |
| nHD | 5 | BPOL | 29.8826 |
| QED | 0.37 |
| Synth | 3.822 |
| Natural Product Likeliness | 1.749 |
| NR-PPAR-gamma | 0.915 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.631 |
| HIA | 0.806 |
| CACO-2 | -5.673 |
| MDCK | 0.0000459 |
| BBB | 0.473 |
| PPB | 0.754474 |
| VDSS | 0.88 |
| FU | 0.151674 |
| CYP1A2-inh | 0.058 |
| CYP1A2-sub | 0.101 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.139 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.683 |
| CYP2d6-inh | 0.062 |
| CYP2d6-sub | 0.437 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.052 |
| CL | 3.052 |
| T12 | 0.39 |
| hERG | 0.03 |
| Ames | 0.646 |
| ROA | 0.025 |
| SkinSen | 0.037 |
| Carcinogencity | 0.456 |
| EI | 0.016 |
| Respiratory | 0.034 |
| NR-Aromatase | 0.903 |
| Antiviral | Yes |
| Prediction | 0.853176 |